Danielle Luciano, MD
Gynecology · Southington, CTNPI 1447239413
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $1,168 of the $1,593 with a category attached, or 73.3%. Regeneron accounts for 73.3% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $1,241, 6.9 times the $179 reported in 2019.
Across 12 payments — averaging $132.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron$1K
- AbbVie$161
- Ferring International Pharmascience Center US$127
- Hologic Sales And Service, LLC$73
- Applied Medical Resources Corporation$31
- Sumitomo Pharma America, Inc.$17
- plus $16 from 1 others
Across 1 payment — averaging $1000.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ferring International Pharmascience Center US$1K
What the payments were for
- Consulting fees$1,16873%
- Food & beverage$39025%
- Education$352%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron | 2 | $1,168 |
| AbbVie | 5 | $161 |
| Ferring International Pharmascience Center US | 1 | $127 |
| Hologic Sales And Service, LLC | 1 | $73 |
| Applied Medical Resources Corporation | 1 | $31 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Gynesonics, Inc. | 1 | $16 |
How this compares
$1,593 in reported general payments places this provider in the 75th percentile of 39 gynecology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 13 | $5,851 |
| YuvafemEstradiol | 29 | $3,483 |
| Estradiol | 15 | $527 |
| Norethindrone Acetate | 21 | $362 |
Paid to pharmacies, not to this prescriber.
Other gynecology in Southington
- Scott ChudnoffStamford$30K
- Karli GoldsteinGreenwich$8K
- Silvio MandaraStamford$4K
- Roslyn ChosakNew Haven$3K
- Thomas McNameeNew Haven$3K
- Clare ManziMiddletown$2K
- Felice CollitonHartford$2K
- Elena Poloukhine MackenziePlainfield$2K
- Julie MalkinBristol$2K
- Ann StrongGuilford$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.